Additional baricitinib loading dose improves clinical outcome in COVID-19
Pneumonia associated with coronavirus disease 2019 (COVID-19) has been accounted for high mortality rate in severe COVID-19 worldwide, and additional serious scarcity of standard and effective anti-inflammatory drug in COVID-19 pneumonia management is a big challenge. Baricitinib, a Janus kinase (JA...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
De Gruyter
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/fa98f059064f41fa9868c28725b9263a |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!